<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03772444</url>
  </required_header>
  <id_info>
    <org_study_id>EC/2017/1476</org_study_id>
    <nct_id>NCT03772444</nct_id>
  </id_info>
  <brief_title>Use of Beetroot Juice to Protect Against Postoperative Ileus (POI) Following Colorectal Surgery: a Pilot Study.</brief_title>
  <acronym>BEET IT</acronym>
  <official_title>Use of Beetroot Juice to Protect Against Postoperative Ileus (POI) Following Colorectal Surgery: a Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BEET IT study investigates the possible protective effect of beetroot juice on POI
      following colorectal surgery in (partially) blinded single-center phase 2 randomized trial
      (pilot study).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative ileus (POI) is a transient impairment of gastrointestinal motility following
      abdominal surgery, which leads to increased morbidity, prolonged hospitalization and
      increased healthcare cost. The pathogenesis of POI involves inflammation and oxidative
      stress, similar to ischemia/reperfusion injury that can be counteracted with beetroot juice.
      Beetroot juice is a source of inorganic nitrate, which by conversion of nitrate to nitrite in
      the body, exerts its protective effect. We before demonstrated in a preclinical model that
      administration of exogenous nitrite was shown to protect against POI. The aim of this pilot
      study is to investigate the possible protective effect of beetroot juice ingestion on POI
      following colorectal surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Patients undergoing colorectal surgery will be randomized (n=10) to receive one week daily 70 ml of beetroot juice (~ 7 mmol inorganic nitrate) or (n=10) an equivalent volume of nitrate-depleted beetroot juice (control group 1). An additional control group (n=10) is added to the pilot study, in which patients will receive an equivalent volume of water (control group 2); this allows us to investigate whether the antioxidants present in beetroot juice contribute to the protective effect of beetroot juice in POI. Beetroot juice and nitrate-depleted beetroot juice cause discoloration of urine (beeturia) and feces from the purple betacyanin pigments in beetroot; for the control group that receives water, this will not be the case and blinding for this group is thus not possible.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time until recovery of gastrointestinal function.</measure>
    <time_frame>up to 30 days after surgery</time_frame>
    <description>Recovery of gastrointestinal function is defined as the interval (in days) from the end of surgery until passage of stool AND tolerance of solid food.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time until passage of stool, flatus or until tolerance of (semi-)solid oral diet (in days).</measure>
    <time_frame>up to 30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall post-operative complication rate defined according to the Clavien-Dindo Classification.</measure>
    <time_frame>3 months postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of prolonged postoperative ileus.</measure>
    <time_frame>up to 30 days after surgery</time_frame>
    <description>Prolonged postoperative ileus is defined as presence of 2 or more of the following criteria on or after day 4 postoperatively: nausea or vomiting, inability to tolerate a solid or semi-solid oral diet, abdominal distension, absence of flatus and stool, radiological evidence of ileus.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Postoperative Ileus</condition>
  <arm_group>
    <arm_group_label>Beetroot juice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group 1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group 2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Beetroot juice</intervention_name>
    <description>Patients will drink 70 ml of beetroot juice daily in the week prior to surgery; the last dose will be administered via the nasogastric tube just before the start of the procedure.</description>
    <arm_group_label>Beetroot juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nitrate-depleted beetroot juice</intervention_name>
    <description>Patients will drink 70 ml of nitrate-depleted beetroot juice daily in the week prior to surgery; the last dose will be administered via the nasogastric tube just before the start of the procedure.</description>
    <arm_group_label>Control group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Water</intervention_name>
    <description>Patients will drink 70 ml of water in the week prior to surgery; the last dose will be administered via the nasogastric tube just before the start of the procedure.</description>
    <arm_group_label>Control group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ All patients undergoing colonic or upper rectum laparoscopic surgery.

        Exclusion Criteria:

          -  Pregnancy or breast feeding

          -  Psychiatric pathology capable of affecting comprehension and judgment faculty

          -  History of metastatic disease

          -  History of prior abdominal bowel surgery

          -  Abdominal radiation treatment

          -  Chronic constipation (defined as two or fewer bowel movements per week)

          -  Gut motility influencing agents (e.g. tricyclic antidepressants, chronic use of
             laxatives)

          -  Frequent use of mouthwash, as this affects the enterosalivary circulation of nitrate

          -  Current use of broad-spectrum antibiotics, which will affect the oral flora and likely
             affect the nitrate reductase activity

          -  More than one bowel anastomosis during this surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wim Ceelen</last_name>
    <phone>+32(0)93326251</phone>
    <email>wim.ceelen@ugent.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarah Cosyns</last_name>
    <phone>+32(0)93321562</phone>
    <email>sarah.cosyns@ugent.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wim Ceelen</last_name>
      <phone>+32(0)93326251</phone>
      <email>wim.ceelen@ugent.be</email>
    </contact>
    <investigator>
      <last_name>Sarah Cosyns</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 5, 2018</study_first_submitted>
  <study_first_submitted_qc>December 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2018</study_first_posted>
  <last_update_submitted>December 11, 2018</last_update_submitted>
  <last_update_submitted_qc>December 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Ghent</investigator_affiliation>
    <investigator_full_name>GIHeelkunde</investigator_full_name>
    <investigator_title>Prof. Dr. Wim Ceelen</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ileus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

